<DOC>
	<DOCNO>NCT00162474</DOCNO>
	<brief_summary>The anticoagulant effect warfarin varies greatly among individual . Some variability attribute difference activity CYP2C9 , predominant enzyme involve metabolism S-warfarin . The present study design define difference warfarin metabolism among healthy individual carry different CYP2C9 genotype . In addition , study define correlation phenytoin metabolic ratio , marker CYP2C9 activity vivo , warfarin metabolism .</brief_summary>
	<brief_title>Determinants Warfarin Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Phenytoin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Age range 2050 year old The absence significant disease state Known hypersensitivity warfarin phenytoin The presence significant disease state Regular use drug ( include birth control pill )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>